Contact
searchSearch
HMP Global
Login

Schizophrenia Topic Center

a caregiver speaks with a doctor
News
Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale
11/14/2024
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving...
11/14/2024
Psych Congress Network
Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
Jonathan Meyer
Quiz
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments?
10/23/2024
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine...
10/23/2024
Psych Congress NP Institute
From Psych Congress NP Institute
dr and patient with brain model
News
Rehospitalization Risk, Treatment Costs Lower With Continued/Maintenance ECT
10/08/2024
Continuing electroconvulsive therapy (ECT) after an acute ECT series is linked with lower rehospitalization risk compared with not continuing ECT, according to study results published in JAMA Psychiatry.
Continuing electroconvulsive therapy (ECT) after an acute ECT series is linked with lower rehospitalization risk compared with not continuing ECT, according to study results published in JAMA Psychiatry.
Continuing electroconvulsive...
10/08/2024
Psych Congress Network
A midlife woman sits on a couch and looks out the window with her chin resting on her fist.
News
Menopausal Hormone Therapy Benefits Midlife Women With Schizophrenia
10/04/2024
Menopausal hormone therapy (MHT) is associated with a 16% lower risk of psychosis relapse in midlife women with schizophrenia or schizoaffective disorder (SSD).
Menopausal hormone therapy (MHT) is associated with a 16% lower risk of psychosis relapse in midlife women with schizophrenia or schizoaffective disorder (SSD).
Menopausal hormone therapy (MHT)...
10/04/2024
Psych Congress Network
FDA approval featuring craig chepke
News
FDA Approves First Schizophrenia Treatment in Over 3 Decades
09/27/2024
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
The US Food and Drug...
09/27/2024
Psych Congress Network
A human hand breaks off a head from a wooden figure against a light blue background
News
TBI Linked With Increased Schizophrenia Risk
08/20/2024
Traumatic brain injury (TBI) increases subsequent schizophrenia risk by 33%, according to study results published in Psychiatry Research.
Traumatic brain injury (TBI) increases subsequent schizophrenia risk by 33%, according to study results published in Psychiatry Research.
Traumatic brain injury (TBI)...
08/20/2024
Psych Congress Network
A brain puzzle against an orange background
News
Most Patients With Schizophrenia Relapse-Free With Paliperidone Palmitate, Open Label Extension Study Finds
08/01/2024
In a 2-year open-label extension study of a 1-year randomized clinical trial, 95.6% of the participating patients with schizophrenia being treated with paliperidone palmitate (PP) remained relapse free for up to 3 years.
In a 2-year open-label extension study of a 1-year randomized clinical trial, 95.6% of the participating patients with schizophrenia being treated with paliperidone palmitate (PP) remained relapse free for up to 3 years.
In a 2-year open-label extension...
08/01/2024
Psych Congress Network
News
Some Antipsychotics Linked To Elevated Pneumonia Risk
07/17/2024
Pneumonia in patients with schizophrenia is associated with the use of specific antipsychotics, according to study findings published in JAMA Psychiatry.
Pneumonia in patients with schizophrenia is associated with the use of specific antipsychotics, according to study findings published in JAMA Psychiatry.
Pneumonia in patients with...
07/17/2024
Psych Congress Network

News Articles

a caregiver speaks with a doctor
News
Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale
11/14/2024
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving...
11/14/2024
Psych Congress Network
Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
dr and patient with brain model
News
Rehospitalization Risk, Treatment Costs Lower With Continued/Maintenance ECT
10/08/2024
Continuing electroconvulsive therapy (ECT) after an acute ECT series is linked with lower rehospitalization risk compared with not continuing ECT, according to study results published in JAMA Psychiatry.
Continuing electroconvulsive therapy (ECT) after an acute ECT series is linked with lower rehospitalization risk compared with not continuing ECT, according to study results published in JAMA Psychiatry.
Continuing electroconvulsive...
10/08/2024
Psych Congress Network
A midlife woman sits on a couch and looks out the window with her chin resting on her fist.
News
Menopausal Hormone Therapy Benefits Midlife Women With Schizophrenia
10/04/2024
Menopausal hormone therapy (MHT) is associated with a 16% lower risk of psychosis relapse in midlife women with schizophrenia or schizoaffective disorder (SSD).
Menopausal hormone therapy (MHT) is associated with a 16% lower risk of psychosis relapse in midlife women with schizophrenia or schizoaffective disorder (SSD).
Menopausal hormone therapy (MHT)...
10/04/2024
Psych Congress Network
FDA approval featuring craig chepke
News
FDA Approves First Schizophrenia Treatment in Over 3 Decades
09/27/2024
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
The US Food and Drug...
09/27/2024
Psych Congress Network
A human hand breaks off a head from a wooden figure against a light blue background
News
TBI Linked With Increased Schizophrenia Risk
08/20/2024
Traumatic brain injury (TBI) increases subsequent schizophrenia risk by 33%, according to study results published in Psychiatry Research.
Traumatic brain injury (TBI) increases subsequent schizophrenia risk by 33%, according to study results published in Psychiatry Research.
Traumatic brain injury (TBI)...
08/20/2024
Psych Congress Network
A brain puzzle against an orange background
News
Most Patients With Schizophrenia Relapse-Free With Paliperidone Palmitate, Open Label Extension Study Finds
08/01/2024
In a 2-year open-label extension study of a 1-year randomized clinical trial, 95.6% of the participating patients with schizophrenia being treated with paliperidone palmitate (PP) remained relapse free for up to 3 years.
In a 2-year open-label extension study of a 1-year randomized clinical trial, 95.6% of the participating patients with schizophrenia being treated with paliperidone palmitate (PP) remained relapse free for up to 3 years.
In a 2-year open-label extension...
08/01/2024
Psych Congress Network
News
Some Antipsychotics Linked To Elevated Pneumonia Risk
07/17/2024
Pneumonia in patients with schizophrenia is associated with the use of specific antipsychotics, according to study findings published in JAMA Psychiatry.
Pneumonia in patients with schizophrenia is associated with the use of specific antipsychotics, according to study findings published in JAMA Psychiatry.
Pneumonia in patients with...
07/17/2024
Psych Congress Network
a doctor writes notes
News
Subcutaneous Olanzapine Long-Acting Injection Meets Efficacy Endpoint in Phase 3 Trial
06/25/2024
An investigational, once-monthly, subcutaneous long-acting injection of olanzapine called TEV-‘749 met its primary endpoint in the efficacy portion of the phase 3 SOLARIS trial.
An investigational, once-monthly, subcutaneous long-acting injection of olanzapine called TEV-‘749 met its primary endpoint in the efficacy portion of the phase 3 SOLARIS trial.
An investigational,...
06/25/2024
Psych Congress Network
A doctor takes notes on paper on a clipboard sitting on a desk
News
Third Xanomeline-Trospium Trial Shows Improvement in Schizophrenia Symptoms
06/18/2024
Xanomeline-trospium chloride was efficacious and well-tolerated in adults with schizophrenia experiencing acute psychosis, according to trial results published in JAMA Psychiatry. “In the phase 3 EMERGENT-3 trial in people with...
Xanomeline-trospium chloride was efficacious and well-tolerated in adults with schizophrenia experiencing acute psychosis, according to trial results published in JAMA Psychiatry. “In the phase 3 EMERGENT-3 trial in people with...
Xanomeline-trospium chloride was...
06/18/2024
Psych Congress Network
a caregiver speaks with a doctor
News
Caregivers Confirm Usability of Schizophrenia Cognition Rating Scale
11/14/2024
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving unpaid and professional caregivers of patients with schizophrenia confirmed the content and usability of the Schizophrenia Cognition Rating Scale (SCoRS).
A qualitative study involving...
11/14/2024
Psych Congress Network
Adults Who Smoke Have More Chronic Pain, Use More Opioids
News
Adults Who Smoke Have More Chronic Pain, Use More Opioids
11/07/2024
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain, prescription opioid use, and severe work limitations rise with the number of cigarettes smoked daily, according to study results published in the American Journal of Preventive Medicine.
Rates of chronic pain,...
11/07/2024
Psych Congress Network
Patient survey
News
Patient Survey Identifies Barriers to TD Treatment
11/06/2024
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive dyskinesia (TD) diagnosis include a lack of communication with the health care professional, lack of a physical exam, and low educational and socioeconomic status, according to a survey of adults with TD symptoms.
Key barriers to tardive...
11/06/2024
Psych Congress Network
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
depression stock photo
News
Add-on Lumateperone Eases MDD in Patients With Inadequate Antidepressant Response
11/04/2024
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the atypical antipsychotic lumateperone improved depressive symptoms and severity more than adjunctive placebo in patients with MDD with inadequate response to previous antidepressant therapy, according to a poster...
Adjunctive treatment with the...
11/04/2024
Psych Congress Network
Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
A person steps onto a scale
News
Neuropsychiatric Side Effects Reported With CB1 Weight-Loss Drug
10/16/2024
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with statistically significant weight loss, but the drug was also linked with mild to moderate neuropsychiatric side effects.
Monlunabant was associated with...
10/16/2024
Psych Congress Network
Increase in Suicidality Associated With FDA Black Box Warning Implementation
News
Increase in Suicidality Associated With FDA Black Box Warning Implementation
10/11/2024
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic...
Black box warnings on...
10/11/2024
Psych Congress Network
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
News
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
10/09/2024
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may...
10/09/2024
Psych Congress Network

Quizzes

Jonathan Meyer
Quiz
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments?
10/23/2024
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine...
10/23/2024
Psych Congress NP Institute
quiz
Quiz
Which symptoms of schizophrenia must be present to make a diagnosis?
06/21/2024
Two of the 5 characteristic symptoms of schizophrenia must be present for a diagnosis to be made. At least one of these must be which of the following, according to the DSM-5-TR? Take the quiz!
Two of the 5 characteristic symptoms of schizophrenia must be present for a diagnosis to be made. At least one of these must be which of the following, according to the DSM-5-TR? Take the quiz!
Two of the 5 characteristic...
06/21/2024
Psych Congress Network
In an illustrated cartoon style, a man sits on the ground with his head in his hands
Quiz
Global Schizophrenia Care Rates
04/15/2024
Put your knowledge to the test with this quick quiz!
Put your knowledge to the test with this quick quiz!
Put your knowledge to the test...
04/15/2024
Psych Congress Network
Psych Congress Network Quiz
Quiz Series
Decoding Psychotic Symptoms in Schizophrenia Part 2
12/15/2023
Which term refers to a psychotic symptom experienced with schizophrenia characterized by strong beliefs that are not true and may seem irrational to others? Take the quiz!
Which term refers to a psychotic symptom experienced with schizophrenia characterized by strong beliefs that are not true and may seem irrational to others? Take the quiz!
Which term refers to a psychotic...
12/15/2023
Psych Congress Network
quiz
Quiz
Decoding Psychotic Symptoms in Schizophrenia Part 1
12/05/2023
Which term refers to a psychotic symptom experienced with schizophrenia characterized by unusual or illogical ways of thinking, difficulty organizing thoughts and speech, stopping mid-thought, or jumping between unrelated topics?
Which term refers to a psychotic symptom experienced with schizophrenia characterized by unusual or illogical ways of thinking, difficulty organizing thoughts and speech, stopping mid-thought, or jumping between unrelated topics?
Which term refers to a psychotic...
12/05/2023
Psych Congress Network
How many adults does schizophrenia affect globally?
Quiz
How many adults does schizophrenia affect globally?
11/14/2023
Do you think you know this statistic?
Do you think you know this statistic?
Do you think you know this...
11/14/2023
Psych Congress Network
Quiz question clip art schizophrenia
Quiz
Schizophrenia Prognosis in Men Compared With Women
11/03/2023
T or F: According to the DSM-5-TR, men have more prominent negative symptoms, cognitive impairment, and generally worse functional outcomes than women.
T or F: According to the DSM-5-TR, men have more prominent negative symptoms, cognitive impairment, and generally worse functional outcomes than women.
T or F: According to the...
11/03/2023
Psych Congress Network
Quiz
How many genetic variants linked to schizophrenia may contribute to its development?
10/16/2023
How many of the 5000 genetic variants previously linked to schizophrenia through genome-wide studies were found to have the potential for biological activity important for developing the psychiatric condition?
How many of the 5000 genetic variants previously linked to schizophrenia through genome-wide studies were found to have the potential for biological activity important for developing the psychiatric condition?
How many of the 5000 genetic...
10/16/2023
Psych Congress Network
How did VR-based therapy affect social cognition in patients with schizophrenia?
Quiz
How did VR-based therapy affect social cognition in patients with schizophrenia?
09/22/2023
Test your knowledge!
Test your knowledge!
Test your knowledge!
09/22/2023
Psych Congress Network
Can schizophrenia be diagnosed in patients with autism spectrum disorders?
Quiz
Can schizophrenia be diagnosed in patients with ASDs?
04/13/2023
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
04/13/2023
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Expert Insights Quiz
LAIs and Telehealth Psychiatric Care
10/24/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
10/24/2024
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
Adult ADHD Diagnosis Rates
10/23/2024
Take the quiz to test your knowledge!
Take the quiz to test your knowledge!
Take the quiz to test your...
10/23/2024
Psych Congress Network
Jonathan Meyer
Quiz
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments?
10/23/2024
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine receptor activators differ from traditional antipsychotic treatments? Take the quiz to find out!
How do muscarinic acetylcholine...
10/23/2024
Psych Congress NP Institute
pop quiz
Quiz
Esketamine Dosing Schedule for Treatment-Resistant Depression
10/01/2024
During the induction and maintenance phases of esketamine treatment, how frequently should the medication be administered to treat TRD? Take the quiz to test your psychopharmacology knowledge.
During the induction and maintenance phases of esketamine treatment, how frequently should the medication be administered to treat TRD? Take the quiz to test your psychopharmacology knowledge.
During the induction and...
10/01/2024
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Telehealth Versus In-Person Psychiatric Care
09/19/2024
Do you know what the data from randomized control trials say?
Do you know what the data from randomized control trials say?
Do you know what the data from...
09/19/2024
Psych Congress Network
How many ADHD prescriptions are affected by the med shortage?
Quiz
How many ADHD prescriptions are affected by the med shortage?
09/17/2024
Take a quick poll on your recent prescribing practices!
Take a quick poll on your recent prescribing practices!
Take a quick poll on your recent...
09/17/2024
Psych Congress Network
Symptom Reduction in Bipolar Disorder Treatment
Expert Insights Quiz
Symptom Reduction in Bipolar Disorder Treatment
09/13/2024
Test your knowledge
Test your knowledge
Test your knowledge
09/13/2024
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
CDC/AAP Treatment Guidelines for Pediatric ADHD
09/11/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
09/11/2024
Psych Congress Network
A person completes a puzzle of a profile of a head, with a piece missing from where the brain is located.
Quiz
Considerations When Prescribing Deutetrabenazine for Tardive Dyskinesia
09/10/2024
Put your clinical knowledge to the test with this quiz!
Put your clinical knowledge to the test with this quiz!
Put your clinical knowledge to...
09/10/2024
Psych Congress Network
A person completes a puzzle of a profile of a head, with a piece missing from where the brain is located.
Quiz
Considerations When Prescribing Deutetrabenazine for Tardive Dyskinesia
09/10/2024
Put your clinical knowledge to the test with this quiz!
Put your clinical knowledge to the test with this quiz!
Put your clinical knowledge to...
09/10/2024
Psych Congress Network

Practice Tools

Saundra's Corner
Brief Adherence Rating Scale (BARS)
09/28/2016
  The BARS scale is available in the public domain, allowing unrestricted use of this scale. An electronic copy of the BARS scale can be requested from Dr. Byerly at matt.byerly@utsouthwestern.edu .     Strengths...
  The BARS scale is available in the public domain, allowing unrestricted use of this scale. An electronic copy of the BARS scale can be requested from Dr. Byerly at matt.byerly@utsouthwestern.edu .     Strengths...
  The BARS scale is...
09/28/2016
Psych Congress Network
Saundra's Corner
Medication Adherence Rating Scale (MARS)
01/29/2019
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for Medication Adherence Rating Scale (MARS) - page 7      The total score ranges from 0-10 with a higher score indicating better adherence   Strengths Self-report...
  Click here for...
01/29/2019
Psych Congress Network
Saundra's Corner
Sheehan Disability Scale (SDS)
01/28/2019
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS How to Use The SDS is a brief, 5-item self-report tool that assesses functional impairment in work/school, social life, and family life.  How to Score Total score 0-30 (0 unimpaired, 30 highly...
Click here for website for SDS...
01/28/2019
Psych Congress Network
Saundra's Corner
Brief Psychiatric Rating Scale (BPRS)
01/28/2019
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
  How to Use The Brief Psychiatric Rating Scale (BPRS) is a comprehensive 24-item symptom scale. The BPRS is used as part of a clinical interview in which the clinician makes...
...
01/28/2019
Psych Congress Network
Saundra's Corner
The Mini International Neuropsychiatric Interview
01/28/2019
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is a widely used psychiatric structured diagnostic interview instrument.  To keep the interview brief, tell the patient the interview is structured and requires only “yes” or “no” answers.   The MINI...
How to Use The MINI is...
01/28/2019
Psych Congress Network
Saundra's Corner
MINI Screen
01/28/2019
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen is a subset (2 pages) of the complete MINI and acts as a tool to refer healthcare providers to the complete MINI.   Click here for the website for the MINI Screen     How to...
How to Use The MINI Screen...
01/28/2019
Psych Congress Network
Saundra's Corner
Patient Health Questionnaire (PHQ-9)
01/28/2019
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health Questionnaire (PHQ-9) is a brief, 9-item self-report screening tool that may help identify symptoms that could relate to depression. The PHQ-9 was developed for use in primary care...
How to Use The Patient Health...
01/28/2019
Psych Congress Network
Saundra's Corner
WHO (Five) Well-Being Index (WHO-5)
01/28/2019
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated on 6-point Likert scale Subjective quality of life based on positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interest (being interested in...
How to Use Five items rated...
01/28/2019
Psych Congress Network
Saundra's Corner
Beck Depression Inventory-II (BDI-II)
01/28/2019
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to Use The Beck Depression Inventory-II (BDI-II): 1996 revision of the BDI 21-item self-report multiple-choice inventory ~ 10 minutes to...
How to...
01/28/2019
Psych Congress Network
Saundra's Corner
Mood Disorder Questionnaire (MDQ)
01/28/2019
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder Questionnaire (MDQ) can be administered either by the clinician or self-administered by the patient.   The MDQ consists of 15 questions and takes about 5 minutes to complete. The first 13 questions about...
How to Use The Mood Disorder...
01/28/2019
Psych Congress Network
Saundra's Corner
Hamilton Anxiety Rating Scale (HAM-A)
01/28/2019
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
  Click here for a PDF of the HAM-A     Developed in 1959 by Dr. M. Hamilton, the scale has proven useful not only in following individual patients but also in...
...
01/28/2019
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use